Mice Transgenic for IL-1 Receptor Antagonist Protein Are Resistant to Herpetic Stromal Keratitis: Possible Role for IL-1 in Herpetic Stromal Keratitis Pathogenesis

Journal of Immunology

Volumn 172, Issue 6, 2004, Pages 3736-3744

  Biswas, Partha S ^a   Banerjee, Kaustuv ^a   Kim, Bumseok ^a   Rouse, Barry T ^a,b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLINDNESS; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA STROMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; INFECTION RESISTANCE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

EID: 1542619255     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.6.3736     Document Type: Article

References (40)

1. Streilein, J. W., M. R. Dana, and B. R. Ksander. 1997. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today 18:443.
2. Russell, R. G., M. P. Nasisse, H. S. Larsen, and B. T. Rouse. 1984. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest. Ophthalmol. Visual Sci. 25:938.
3. Niemialtowski, M. G., and B. T. Rouse. 1992. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J. Immunol. 148:1864.
4. Tumpey, T. M., S. H. Chen, J. E. Oakes, and R. N. Lausch. 1996. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:898.
5. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158:1383.
6. Lee, S., M. Zheng, B. Kim, and B. T. Rouse. 2002. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J. Clin. Invest. 110:1105.
7. Daheshia, M., S. Kanangat, and B. T. Rouse. 1998. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp. Eye Res. 67:619.
8. Zheng, M., S. Deshpande, S. Lee, N. Ferrara, and B. T. Rouse. 2001. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 75:9828.
9. Kwong, A. D., J. A. Kruper, and N. Frenkel. 1988. Herpes simplex virus virion host shutoff function. J. Virol. 62:912.
10. Kanangat, S., J. S. Babu, D. M. Knipe, and B. T. Rouse. 1996. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective up-regulation of IL-6 gene expression. Virology 219:295.
11. Paludan, S. R. 2001. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J. Virol. 75:8008.
12. Tran, M. T., D. A. Dean, R. N. Lausch, and J. E. Oakes. 1998: Membranes of herpes simplex virus type-1-infected human comeal epithelial cells are not permeabilized to macromolecules and therefore do not release IL-1α. Virology 244:74.
13. Thomas, J., S. Kanangat, and B. T. Rouse. 1998. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J. Interferon Cytokine Res. 18:681.
14. Staats, H. F., and R. N. Lausch. 1993. Cytokine expression in vivo during murine herpetic stromal keratifis: effect of protective antibody therapy. J. Immunol. 151:277.
15. Thompson, R. C., D. J. Dripps, and S. P. Eisenberg. 1992. Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease. Int. J. Immunopharmacol. 14:475.
16. Kary, S., and G. R. Burmester. 2003. Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis. Int. J. Clin. Pract. 57:231.
17. Cominelli, F., C. C. Nast, B. D. Clark, R. Schindler, R. Lierena, V. E. Eysselein, R. C. Thompson, and C. A. Dinarello. 1990. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J. Clin. Invest. 86:972.
18. Mikuniya, T., S. Nagai, M. Takeuchi, T. Mio, Y. Hoshino, H. Miki, M. Shigematsu, K. Hamada, and T. Izumi. 2000. Significance of the interleukin-1 receptor antagonist/interleukin-1β ratio as a prognostic factor in patients with pulmonary sarcoidosis. Respiration 67:389.
19. Yano, S., H. Nokihara, A. Yamamoto, H. Goto, H. Ogawa, T. Kanematsu, T. Miki, H. Uehara, Y. Saijo, T. Nukiwa, and S. Sone. 2003. Multifunctional interleukin-1β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci. 94:244.
20. Salven, P., K. Hattori, B. Heissig, and S. Rafii. 2002. Interleukin-1α promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16:1471.
21. Garat, C., and W. P. Arend. 2003. Intracellular IL-1Ra type I inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-κB pathways. Cytokine 23:31.
22. Spear, P. G., and B. Roizman. 1972. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J. Virol. 9:143.
23. Dana, M. R., S. N. Zhu, and J. Yamada. 1998. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17:403.
24. Lausch, R. N., S. H. Chen, T. M. Tumpey, Y. H. Su, and J. E. Oakes. 1996. Early cytokine synthesis in the excised mouse cornea. J. Interferon Cytokine Res. 16:35.
25. -/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J. Immunol. 172:1237.
26. Zheng, M., D. M. Klinman, M. Gierynska, and B. T. Rouse. 2002. DNA containing CpG motifs induces angiogenesis. Proc. Natt. Acad. Sci. USA 99:8944.
27. Fenton, R. R., S. Molesworth-Kenyon, J. E. Oakes, and R. N. Lausch. 2002. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Visual Sci. 43:737.
28. Deshpande, S., M. Zheng, S. Lee, K. Banerjee, S. Gangappa, U. Kumaraguru, and B. T. Rouse. 2001. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 167:2902.
29. Zheng, M., M. A. Schwarz, S. Lee, U. Kumaraguru, and B. T. Rouse. 2001. Control of stromal keratitis by inhibition of neovascularization. Am. J. Pathol. 159:1021.
30. Yan, X. T., T. M. Tumpey, S. L. Kunkel, J. E. Oakes, and R. N. Lausch. 1998. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest. Ophthalmol. Visual Sci. 39:1854.
31. Calkins, C. M., D. D. Bensard, B. D. Shames, E. J. Pulido, E. Abraham, N. Fernandez, X. Meng, C. A. Dinarello, and R. C. McIntyre, Jr. 2002. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. J. Endotoxin Res. 8:59.
32. Yoshida, K., I. Ichimiya, M. Suzuki, and G. Mogi. 1999. Effect of proinflammatory cytokines on cultured spiral ligament fibrocytes. Hear. Res. 137:155.
33. Kasama, T., K. Kobayashi, N. Yajima, F. Shiozawa, Y. Yoda, H. T. Takeuchi. Y. Mori, M. Negishi, H. Ide, and M. Adachi. 2000. Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA). Clin. Exp. Immunol. 121:533.
34. Scapini, P., F. Calzetti, and M. A. Cassatella. 1999. On the detection of neutrophil-derived vascular endothelial growth factor (VEGF). J. Immunol. Methods 232:121.
35. Moore, J. E., T. C. McMullen, I. L. Campbell, R. Rohan, Y. Kaji, N. A. Afshari, T. Usui, D. B. Archer, and A. P. Adamis. 2002. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy. Invest. Ophthalmol. Visual Sci. 43:2905.
36. Saijo, Y., M. Tanaka, M. Miki, K. Usui, T. Suzuki, M. Maemondo, X. Hong, R. Tazawa, T. Kikuchi, K. Matsushima, and T. Nukiwa. 2002. Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol. 169:469.
37. Nakahara, H., J. Song, M. Sugimoto, K. Hagihara, T. Kishimoto, K. Yoshizaki, and N. Nishimoto. 2003. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum. 48:1521.
38. Wei, L. H., M. L. Kuo, C. A. Chen, C. H. Chou, K. B. Lai, C. N. Lee, and C. Y. Hsieh. 2003. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22:1517.
39. Ristimaki, A., K. Narko, B. Enholm, V. Joukov, and K. Alitalo. 1998. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J. Biol. Chem. 273:8413.
40. Ferrara, N., H. P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9:669.